Keiji Fukuda
Dr. Keiji Fukuda is director and a clinical professor at The University of Hong Kong School of Public Health. He previously worked for the CDC and the WHO.
Early life and education[edit | edit source]
Dr. Fukuda earned a BA from Oberlin College,[1] where he studied biology,[2] his MD from the University of Vermont,[1] and an MPH from the University of California, Berkeley.[1] He is board-certified in internal medicine.[2]
Career[edit | edit source]
Dr. Fukuda's early career focused on chronic fatigue syndrome,[1] establishing the Fukuda criteria.
Dr. Fukuda also served as medical epidemiologist in the Viral Exanthems and Herpesvirus Branch of the U.S. National Center for Infectious Diseases[2] and as Chief of Epidemiology in the Influenza Branch of the U.S. Centers for Disease Control and Prevention Centers (CDC).[1] From 2005 to 2016, he worked for the World Health Organization (WHO), serving as Scientist, Coordinator and then Director of the Global Influenza Programme (2005-2008), Assistant Director-General for Health Security and Environment ad interim (2008-2009), Special Adviser on Pandemic Influenza to the Director-General (2009-2010), Assistant Director-General for Health Security (2010-2015) and Special Representative for Antimicrobial Resistance for the Director-General (2015-2016).[1]
Dr. Fukuda currently serves as director and a clinical professor at The University of Hong Kong School of Public Health.[1] In October 2020, senior management team of the University of Hong Kong decided not to renew his contract. Keiji will thus leave the University of Hong Kong in late 2021.
References[edit | edit source]
 | This article is a stub. |
